Table 4.
Name [ref] | Molecular Weight (Da) | Modification | DS 1 | Bioactivities 2 | ||
---|---|---|---|---|---|---|
a | b | c | ||||
AGEW [10] | 1.0 × 105 | - | 0 | − | − | − |
ASS25 [10] | 1.5 × 105 | sulfation | 0.579 | − | − | − |
ASS45 [10] | 6.8 × 104 | 0.624 | + | − | − | |
WGEW [10] | 2.8 × 105 | - | 0 | − | − | − |
WSS25 [10,11,95,96,97] | 6.5 × 104 | sulfation | 0.206 | + | + | + |
WSS45 [10] | 1.9 × 105 | 1.685 | + | − | − | |
M1S [97] | 1.8 × 105 | 1.050 | − | + | − | |
M2S [97] | 1.3 × 105 | 1.220 | − | + | − | |
M3S [97] | 7.5 × 104 | 1.270 | − | + | − | |
M4S [97] | 4.1 × 104 | 1.210 | − | + | − | |
M5S [97] | 1.4 × 104 | 1.050 | − | − | − | |
M6S [97] | 1.2 × 104 | 1.240 | − | − | − | |
M7S [97] | 2.7 × 103 | 1.350 | − | − | − | |
WGES1 [97] | 2.4 × 105 | 0.141 | − | + | − | |
WGES2 [97] | 6.7 × 104 | 0.097 | − | + | − | |
WGES3 [97] | 1.8 × 105 | 0.194 | − | + | − | |
WGES4 [97] | 8.0 × 104 | 0.173 | − | + | − | |
WGES5 [97] | 1.38 × 105 | 0.220 | − | + | − | |
WGES6 [97] | 7.6 × 104 | 0.202 | − | + | − | |
WGEA | 5.7 × 103 | aminopropylation | unknown | − | − | − |
WGEC | 7.3 × 104 | carboxymethylation | − | − | − | |
WGEP | 2.2 × 103 | phosphorylation | − | − | − | |
WGEL | 6.0 × 105 | acetylation | − | − | − |
1 DS is calculated as 162 × %W/(96-80 × %W); %W is the content of SO4 2−. 2 a. Anti-dengue virus; b. antiangiogenesis; c. antiosteoporosis.